This case demonstrates that long-term ketogenic diet therapy in people with type 1 diabetes is possible and has a dual metabolic benefit by improving glycemic control in conjunction with a decrease in insulin use, independent of any changes in body mass/composition, total daily energy intake, or physical activity. The gene discussed is INS; the disease is type 1 diabetes mellitus.